Correspondence and communication
Validation of the laboratory risk indicator for necrotising fasciitis scoring system (LRINEC) in a Northern European population

https://doi.org/10.1016/j.bjps.2016.05.014Get rights and content

Section snippets

Methodology

We sought to validate LRINEC in our population of Northern Europeans using the same methodology of patient selection as the original paper. The study was approved by the local Research and Development team (Ref 15-2046). A search of the Royal Devon & Exeter database using ICD-9 code 728.86 was performed between the years 2000–2010; 74 patients were identified. Patient hospital numbers and dates of admission were used to query the blood results necessary for the calculation of LRINEC from the

Results

Of the 74 identified patients, 32 had LRINEC scores ≧ 6. Our sensitivity is 43.2% (95% CI of 32.5%–54.6%). The original paper's sensitivity was 89.9% (95% CI of 81.9%–94.6%) as per Figure 1.

Discussion

The validation of LRINEC in our group of patients showed a reduced sensitivity of 43.2% (95% CI of 32.5%–54.6%). This is surprising given the vast difference between the original paper's claims and our validation cohort. A control group was purposefully not allocated for our validation study as we were interested in the sensitivity of LRINEC not positive predictive value.

We accept our limitation of a single-centre retrospective study and the data available which did not allow us to test the

Conclusion

The low sensitivity of LRINEC and inappropriately high rate of false negatives in our group of patients has cast doubt on the validity of the LRINEC score making it an inappropriate screening tool in the UK. Use of LRINEC to rule out patients could potentially lead to delayed diagnosis, delayed treatment and worsening outcomes. Further work in this area should be directed towards a scoring system for western populations.

References (5)

There are more references available in the full text version of this article.

Cited by (13)

  • Necrotising fasciitis: Management experience over the last two decades in our hospital

    2022, Revista Espanola de Cirugia Ortopedica y Traumatologia
  • A Systematic Review and Meta-Analysis of the Effectiveness of LRINEC Score for Predicting Upper and Lower Extremity Necrotizing Fasciitis

    2022, Journal of Foot and Ankle Surgery
    Citation Excerpt :

    In addition, 2 articles were determined to not meet the inclusion criteria of reporting LRINEC sensitivity for NF, and were excluded, leaving 8 results in total. Control groups were absent from 3/8 citations (Fig. 2) (19-21). The initial search criterion produced 36 citations.

  • Reliability of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score

    2019, Surgeon
    Citation Excerpt :

    The study is graded as 2– on the hierarchy of evidence. A retrospective single centre study by Al-Hindawi et al. (2016)15 was aimed at evaluating LRINEC score in a UK population. A total of 74 patients were identified over a 10-year period and LRINEC scores were calculated after pathology results.

  • Clinical Mimics: An Emergency Medicine-Focused Review of Cellulitis Mimics

    2017, Journal of Emergency Medicine
    Citation Excerpt :

    Less emergent diagnoses include erysipelas, abscess, felon, paronychia, and gouty arthritis. Cellulitis mimics are shown in Table 4 with diagnosis and treatment pearls (4–6,19–42). Cellulitis is a frequent diagnosis in the ED.

View all citing articles on Scopus
View full text